LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 1097 | 1857 | 3769 | 0.4927 | 0.2844 |
BT-20 | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3297 | 3769 | 0.8748 | 0.8234 |
BT-20 | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1091 | 3769 | 0.2895 | -0.0022 |
BT-20 | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 1097 | 952 | 3769 | 0.2527 | -0.0541 |
BT-20 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 1427 | 3769 | 0.3787 | 0.1235 |
BT-20 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 1796 | 3769 | 0.4766 | 0.2617 |
BT-20 | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3352 | 3769 | 0.8893 | 0.8439 |
BT-20 | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 1097 | 608 | 3769 | 0.1615 | -0.1828 |
BT-20 | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 2343 | 3769 | 0.6217 | 0.4663 |
BT-20 | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1097 | 1471 | 3769 | 0.3904 | 0.1401 |
BT-20 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3391 | 3769 | 0.8998 | 0.8586 |
BT-20 | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3375 | 3769 | 0.8955 | 0.8526 |
BT-20 | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3668 | 3769 | 0.9732 | 0.9621 |
BT-20 | JNK-9L | 0.37 | uM | LJP6 | 72 | hr | 1097 | 1983 | 3769 | 0.5261 | 0.3315 |
BT-20 | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 2874 | 3769 | 0.7626 | 0.6651 |
BT-20 | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3373 | 3769 | 0.8950 | 0.8519 |
BT-20 | LDN-193189 | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3201 | 3769 | 0.8493 | 0.7874 |
BT-20 | Linifanib | 0.37 | uM | LJP6 | 72 | hr | 1097 | 3801 | 3769 | 1.0083 | 1.0118 |
BT-20 | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3689 | 3769 | 0.9787 | 0.9700 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP5 | 72 | hr | 1097 | 917 | 3769 | 0.2433 | -0.0675 |
BT-20 | Mitoxantrone | 0.37 | uM | LJP6 | 72 | hr | 1097 | 994 | 3769 | 0.2638 | -0.0385 |
BT-20 | MK2206 | 0.37 | uM | LJP6 | 72 | hr | 1097 | 2365 | 3769 | 0.6276 | 0.4747 |
BT-20 | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 2260 | 3769 | 0.5997 | 0.4354 |
BT-20 | Nilotinib | 0.37 | uM | LJP5 | 72 | hr | 1097 | 3882 | 3769 | 1.0300 | 1.0423 |
BT-20 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1097 | 2874 | 3769 | 0.7625 | 0.6650 |